Methods applied in process evaluation
| NCD (N=239) | NTD (N=62) | Total (N=303)* | |
| Study design | |||
| Observational studies | 72 (30.4%) | 18 (29.5%) | 92 (30.3%) |
| Feasibility | 41 (17.3%) | 7 (11.5%) | 48 (16.0%) |
| Qualitative study | 73 (30.8%) | 23 (37.7%) | 97 (32.3%) |
| Mixed or multimethods | 51 (21.5%) | 13 (21.3%) | 64 (21.4%) |
| Methods | |||
| Quantitative | 60 (25.1%) | 17 (27.4%) | 78 (25.8%) |
| Mixed or multimethods | 97 (40.6%) | 30 (48.4%) | 127 (41.9%) |
| Qualitative | 82 (34.3%) | 15 (24.2%) | 98 (32.3%) |
| Qualitative methods† | |||
| Individual interviews | 134 (76.1%) | 31 (68.9%) | 166 (74.8%) |
| Focus groups | 60 (35.9%) | 22 (48.9%) | 83 (39.0%) |
| Observations | 34 (20.2%) | 13 (28.9%) | 47 (22.0%) |
| Others | 11 (6.6%) | 5 (11.1%) | 16 (7.5%) |
| Quantitative methods† | |||
| Routine monitoring data | 60 (38.5%) | 20 (43.5%) | 80 (39.4%) |
| Descriptive analysis | 104 (66.7%) | 29 (63.0%) | 133 (65.5%) |
| Advanced quantitative methods | 31 (19.8%) | 8 (17.4%) | 39 (19.2%) |
| Factorial analysis | 4 (2.6%) | – | 5 (2.5%) |
| Integration of process evaluation and main study outcome | |||
| Yes | 169 (70.7%) | 42 (67.7%) | 212 (70.0%) |
| No | 70 (29.3%) | 20 (32.3%) | 91 (30.0%) |
| Team leading the process evaluation | |||
| Completely independent | 35 (14.6%) | 17 (27.4%) | 53 (17.5%) |
| Not independent | 145 (60.7%) | 31 (50.0%) | 176 (58.1%) |
| Not specified | 59 (24.7%) | 14 (22.6%) | 74 (24.4%) |
*The total column includes those studies that were conducted in NCD and NTD area.
†More than one label could be included in one study.
NCD, non-communicable disease; NTD, neglected tropical disease.